These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 18564537)

  • 41. Reduced effect of intravenous antibiotic treatment on sinonasal markers in pulmonary inflammation.
    Doht F; Hentschel J; Fischer N; Lehmann T; Markert UR; Böer K; Pfister W; Pletz MW; Guntinas-Lichius O; Mainz JG
    Rhinology; 2015 Sep; 53(3):249-59. PubMed ID: 26363166
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acute bacterial rhinosinusitis in adults: part II. Treatment.
    Scheid DC; Hamm RM
    Am Fam Physician; 2004 Nov; 70(9):1697-704. PubMed ID: 15554487
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Surfactant protein A and D in chronic rhinosinusitis with nasal polyposis and corticosteroid response.
    Salman S; Akpinar ME; Yigit O; Gormus U
    Am J Rhinol Allergy; 2012; 26(2):e76-80. PubMed ID: 22487281
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pediatric atrophic rhinosinusitis: what can we do?
    Magalhães C; Viana M; Alves V; Nakamura R; Duarte D
    Int J Pediatr Otorhinolaryngol; 2015 May; 79(5):763-5. PubMed ID: 25799383
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Staphylococcus aureus in nasal lavage and biopsy of patients with chronic rhinosinusitis.
    Niederfuhr A; Kirsche H; Deutschle T; Poppert S; Riechelmann H; Wellinghausen N
    Allergy; 2008 Oct; 63(10):1359-67. PubMed ID: 18782116
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of corticosteroids in the treatment of experimental sinusitis.
    Cable BB; Wassmuth Z; Mann EA; Hommer D; Connely G; Klem C; Quance-Fitch FJ; Bolger WE
    Am J Rhinol; 2000; 14(4):217-22. PubMed ID: 10979493
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sinus Microanatomy and Microbiota in a Rabbit Model of Rhinosinusitis.
    Cho DY; Mackey C; Van Der Pol WJ; Skinner D; Morrow CD; Schoeb TR; Rowe SM; Swords WE; Tearney GJ; Woodworth BA
    Front Cell Infect Microbiol; 2017; 7():540. PubMed ID: 29376039
    [No Abstract]   [Full Text] [Related]  

  • 48. In vitro activity of mupirocin on clinical isolates of Staphylococcus aureus and its potential implications in chronic rhinosinusitis.
    Ha KR; Psaltis AJ; Butcher AR; Wormald PJ; Tan LW
    Laryngoscope; 2008 Mar; 118(3):535-40. PubMed ID: 18090864
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy of Primary Collagen Cross-Linking with Photoactivated Chromophore (PACK-CXL) for the Treatment of Staphylococcus aureus-Induced Corneal Ulcers.
    Tal K; Gal-Or O; Pillar S; Zahavi A; Rock O; Bahar I
    Cornea; 2015 Oct; 34(10):1281-6. PubMed ID: 26252742
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Staphylococcal antifagin in combined therapy of chronic purulent sinusitis].
    Magomedov KhR
    Vestn Otorinolaringol; 2008; (5):54-6. PubMed ID: 19065705
    [No Abstract]   [Full Text] [Related]  

  • 51. Developing a mouse model of acute bacterial rhinosinusitis.
    Jin M; Gu Z; Bian Z; Yang J; Cao Z; Yu X; Guo G
    Eur Arch Otorhinolaryngol; 2011 Jun; 268(6):857-61. PubMed ID: 21267587
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bactrim reduces the inflammatory response in a murine model of acute rhinosinusitis.
    Won YS; Brichta A; Baroody F; Boonlayangoor S; Naclerio R
    Rhinology; 2000 Jun; 38(2):68-71. PubMed ID: 10953844
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antibiotics for acute rhinosinusitis.
    Kaiser L; Hirschel B
    Arch Intern Med; 2004 Mar; 164(5):568; author reply 570. PubMed ID: 15006837
    [No Abstract]   [Full Text] [Related]  

  • 54. The successful treatment of gatifloxacin-resistant Staphylococcus aureus keratitis with Zymar (gatifloxacin 0.3%) in a NZW rabbit model.
    Romanowski EG; Mah FS; Yates KA; Kowalski RP; Gordon YJ
    Am J Ophthalmol; 2005 May; 139(5):867-77. PubMed ID: 15860293
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of topical 0.3% ofloxacin with fortified tobramycin plus cefazolin in the treatment of bacterial keratitis.
    Panda A; Ahuja R; Sastry SS
    Eye (Lond); 1999 Dec; 13 ( Pt 6)():744-7. PubMed ID: 10707137
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevalence of biofilm-forming bacteria in chronic rhinosinusitis.
    Prince AA; Steiger JD; Khalid AN; Dogrhamji L; Reger C; Eau Claire S; Chiu AG; Kennedy DW; Palmer JN; Cohen NA
    Am J Rhinol; 2008; 22(3):239-45. PubMed ID: 18588755
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Staphylococcus aureus small colony variants: Prevalence in chronic rhinosinusitis and induction by antibiotics.
    Zhang G; Zhao Y; Hayes AJ; Psaltis AJ; Wormald PJ; Vreugde S
    Allergy; 2018 Dec; 73(12):2403-2405. PubMed ID: 30055001
    [No Abstract]   [Full Text] [Related]  

  • 58. Intracellular residency is frequently associated with recurrent Staphylococcus aureus rhinosinusitis.
    Plouin-Gaudon I; Clement S; Huggler E; Chaponnier C; François P; Lew D; Schrenzel J; Vaudaux P; Lacroix JS
    Rhinology; 2006 Dec; 44(4):249-54. PubMed ID: 17216740
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intravenous antibiotics for chronic rhinosinusitis: are they effective?
    Tanner SB; Fowler KC
    Curr Opin Otolaryngol Head Neck Surg; 2004 Feb; 12(1):3-8. PubMed ID: 14712111
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A comparison of topical chlorhexidine, ciprofloxacin, and fortified tobramycin/cefazolin in rabbit models of Staphylococcus and Pseudomonas keratitis.
    Bu P; Riske PS; Zaya NE; Carey R; Bouchard CS
    J Ocul Pharmacol Ther; 2007 Jun; 23(3):213-20. PubMed ID: 17593004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.